[go: up one dir, main page]

HK1236035B - 用於治疗炎性、代谢性、肿瘤性和自身免疫性疾病的任选稠合的、经杂环基取代的嘧啶衍生物 - Google Patents

用於治疗炎性、代谢性、肿瘤性和自身免疫性疾病的任选稠合的、经杂环基取代的嘧啶衍生物

Info

Publication number
HK1236035B
HK1236035B HK17109799.5A HK17109799A HK1236035B HK 1236035 B HK1236035 B HK 1236035B HK 17109799 A HK17109799 A HK 17109799A HK 1236035 B HK1236035 B HK 1236035B
Authority
HK
Hong Kong
Prior art keywords
substituted
unsubstituted
phenyl
group
alkyl
Prior art date
Application number
HK17109799.5A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1236035A1 (zh
Inventor
Sanne SCHRØDER GLAD
Kim Birkebæk Jensen
Niels Grøn Nørager
Ian SARVARY
Mikkel VESTERGAARD
Alex Haahr Gouliaev
Lene Teuber
Luigi Piero Stasi
Original Assignee
纽韦卢森公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 纽韦卢森公司 filed Critical 纽韦卢森公司
Publication of HK1236035A1 publication Critical patent/HK1236035A1/zh
Publication of HK1236035B publication Critical patent/HK1236035B/zh

Links

HK17109799.5A 2014-08-04 2015-07-31 用於治疗炎性、代谢性、肿瘤性和自身免疫性疾病的任选稠合的、经杂环基取代的嘧啶衍生物 HK1236035B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1450920-2 2014-08-04
SE1451406-1 2014-11-21

Publications (2)

Publication Number Publication Date
HK1236035A1 HK1236035A1 (zh) 2018-03-16
HK1236035B true HK1236035B (zh) 2022-06-17

Family

ID=

Similar Documents

Publication Publication Date Title
EP3177611B1 (en) Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
AU2020408107A1 (en) Compounds active towards nuclear receptors
HK1236035B (zh) 用於治疗炎性、代谢性、肿瘤性和自身免疫性疾病的任选稠合的、经杂环基取代的嘧啶衍生物
HK1236034B (zh) 用於治疗炎性、代谢性、肿瘤性和自身免疫性疾病的任选稠合的、经杂环基取代的嘧啶衍生物
RU2815636C1 (ru) Необязательно конденсированные гетероциклил-замещенные производные пиримидина, пригодные для лечения воспалительных, метаболических, онкологических и аутоиммунных заболеваний
WO2021198956A1 (en) Compounds active towards nuclear receptors
BR112017002217B1 (pt) Composto da fórmula (i), composição farmacêutica, e usos de um composto